Danyelle Winchester1, Luisel Ricks-Santi2, Tshela Mason3, Muneer Abbas4, Robert L Copeland5, Desta Beyene6, Emmanuel Y Jingwi6, Georgia M Dunston7, Yasmine M Kanaan8. 1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, U.S.A. 2. Cancer Research Center, Hampton University, Hampton, VA, U.S.A. 3. National Human Genome Center, Howard University, Washington, DC, U.S.A. 4. National Human Genome Center, Howard University, Washington, DC, U.S.A. Department of Microbiology, College of Medicine, Howard University, Washington, DC, U.S.A. 5. Department of Pharmacology, College of Medicine, Howard University, Washington, DC, U.S.A. 6. Cancer Center, Howard University, Washington, DC, U.S.A. 7. National Human Genome Center, Howard University, Washington, DC, U.S.A. Department of Microbiology, College of Medicine, Howard University, Washington, DC, U.S.A. Cancer Center, Howard University, Washington, DC, U.S.A. 8. Department of Microbiology, College of Medicine, Howard University, Washington, DC, U.S.A. Cancer Center, Howard University, Washington, DC, U.S.A. ymkanaan@howard.edu.
Abstract
BACKGROUND/AIM: Several studies reported that patients with benign prostatic hyperplasia (BPH) experienced a 10% increased incidence of prostate cancer (PCa) after the first 5 years of diagnosis. We investigated the association between single nucleotide polymorphisms (SNPs) in the promoter of Serine Protease Inhibitor Kazal Type 1 (SPINK1) and the increased risk of BPH and PCa. MATERIALS AND METHODS: We genotyped three SNPs in a cases-control study, including BPH and PCa cases. Multiple logistic regression models were applied to analyze clinical and genotypic data. RESULTS: We found an inverse association between SNP rs10035432 and BPH under the log-additive (p=0.007) model. No association was found between these SNPs and PCa risk. However, we observed a possible association between rs1432982 and lower-grade PCa (p=0.05) under the recessive model. CONCLUSION: SPINK1 promoter variants are likely to be associated with the risk of BPH. Copyright
BACKGROUND/AIM: Several studies reported that patients with benign prostatic hyperplasia (BPH) experienced a 10% increased incidence of prostate cancer (PCa) after the first 5 years of diagnosis. We investigated the association between single nucleotide polymorphisms (SNPs) in the promoter of Serine Protease Inhibitor Kazal Type 1 (SPINK1) and the increased risk of BPH and PCa. MATERIALS AND METHODS: We genotyped three SNPs in a cases-control study, including BPH and PCa cases. Multiple logistic regression models were applied to analyze clinical and genotypic data. RESULTS: We found an inverse association between SNP rs10035432 and BPH under the log-additive (p=0.007) model. No association was found between these SNPs and PCa risk. However, we observed a possible association between rs1432982 and lower-grade PCa (p=0.05) under the recessive model. CONCLUSION:SPINK1 promoter variants are likely to be associated with the risk of BPH. Copyright
Authors: Asmahan Ali El Ezzi; Wissam Rateeb Zaidan; Mohammed Ahmed El-Saidi; Nabil Al-Ahmadieh; Jeffrey Benjamin Mortenson; Ruhul Haque Kuddus Journal: Asian Pac J Cancer Prev Date: 2014
Authors: Riina-Minna Väänänen; Hans Lilja; Leni Kauko; Pauliina Helo; Henna Kekki; Angel M Cronin; Andrew J Vickers; Martti Nurmi; Kalle Alanen; Anders Bjartell; Kim Pettersson Journal: Urology Date: 2014-02 Impact factor: 2.649
Authors: Wendy Weijia Soon; Lance David Miller; Michael A Black; Cyril Dalmasso; Xiu Bin Chan; Brendan Pang; Chee Wee Ong; Manuel Salto-Tellez; Kartiki V Desai; Edison T Liu Journal: EMBO Mol Med Date: 2011-06-08 Impact factor: 12.137
Authors: Jacklyn N Hellwege; Sarah Stallings; Eric S Torstenson; Robert Carroll; Kenneth M Borthwick; Murray H Brilliant; David Crosslin; Adam Gordon; George Hripcsak; Gail P Jarvik; James G Linneman; Parimala Devi; Peggy L Peissig; Patrick A M Sleiman; Hakon Hakonarson; Marylyn D Ritchie; Shefali Setia Verma; Ning Shang; Josh C Denny; Dan M Roden; Digna R Velez Edwards; Todd L Edwards Journal: Sci Rep Date: 2019-04-15 Impact factor: 4.379
Authors: Deli Liu; Jonathan E Shoag; Daniel Poliak; Ramy S Goueli; Vaishali Ravikumar; David Redmond; Aram Vosoughi; Jacqueline Fontugne; Heng Pan; Daniel Lee; Domonique Thomas; Keyan Salari; Zongwei Wang; Alessandro Romanel; Alexis Te; Richard Lee; Bilal Chughtai; Aria F Olumi; Juan Miguel Mosquera; Francesca Demichelis; Olivier Elemento; Mark A Rubin; Andrea Sboner; Christopher E Barbieri Journal: Nat Commun Date: 2020-04-24 Impact factor: 14.919